During the 5th International Congress of Corneal Cross Linking for Keratoconus in Germany, Avedro presented encouraging clinical results for treating keratoconus, a progressive disease of the cornea of the eye. The procedure, known as Keraflex® KXL, is non-incisional and reshapes the cornea without removing any tissue. Keratoconus, or KC, is a cone-shaped protrusion and distortion of the cornea that typically begins in the teenage years or 20’s and afflicts millions of people around the world.

For the full story, Click  Here

Use of hydrogen peroxide solution was associated with the lowest incidence of corneal infiltration among daily hydrogel contact lens wearers, according to a study published in Arch Ophthalmol. The study included 558 patients with myopia who participated in one or more of about 40 trials for 20 hydrogel contact lens and lens solution combinations. Patient assessments were conducted at baseline, 2 weeks, 1 month and 3 months. Data included 840 lens-solution combinations and 2,271 participant-months.

For the full story, Click Here

Paradigm Medical Industries, Inc. announced that it introduced two new products at the annual American Academy of Ophthalmology Meeting in San Francisco. The new products consisted of the Paravue 300, a corneal topographer, and the Surveyor 500, a fully capable corneal topographer with a Scheimpflug technology rotating camera for the measurement of interior ocular structures in the anterior segment.

For the full story here, Click Here

Researchers at Aston University, UK have been awarded over £1 million pounds worth of funding from the BBSRC and the EPSRC to investigate the fundamental processes involved in human vision. The BBSRC project will see the Aston research team conduct psychophysical experiments to study the binocular perception and performance of human observers in order to develop a more complete theory and understanding of binocular spatial vision through successive refinements of a computational model.

Cataract surgery improved vision in patients with any stage–from mild to advanced– AMD in the first study to include an adequate number of advanced AMD patients. Data was obtained from the multicenter, prospective Age-Related Eye Disease Study (AREDS), funded by the National Eye Institute (NEI), which was organized primarily to evaluate the effects of high-dose vitamin and mineral supplements on cataract and AMD.